nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.211	0.367	CbGbCtD
Oxprenolol—SLC22A2—Metformin—type 2 diabetes mellitus	0.0966	0.168	CbGbCtD
Oxprenolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0781	0.136	CbGbCtD
Oxprenolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0721	0.126	CbGbCtD
Oxprenolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0592	0.103	CbGbCtD
Oxprenolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0567	0.099	CbGbCtD
Oxprenolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.00189	0.313	CrCbGaD
Oxprenolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.00162	0.269	CrCbGaD
Oxprenolol—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.00125	0.00416	CcSEcCtD
Oxprenolol—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00123	0.00409	CcSEcCtD
Oxprenolol—Hypoglycaemia—Metformin—type 2 diabetes mellitus	0.00123	0.00408	CcSEcCtD
Oxprenolol—Fatigue—Nateglinide—type 2 diabetes mellitus	0.00123	0.00408	CcSEcCtD
Oxprenolol—Arthralgia—Rosiglitazone—type 2 diabetes mellitus	0.00121	0.00404	CcSEcCtD
Oxprenolol—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.0012	0.00401	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Valsartan—type 2 diabetes mellitus	0.0012	0.004	CcSEcCtD
Oxprenolol—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00119	0.00397	CcSEcCtD
Oxprenolol—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00117	0.00388	CcSEcCtD
Oxprenolol—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00114	0.00379	CcSEcCtD
Oxprenolol—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00112	0.00374	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Repaglinide—type 2 diabetes mellitus	0.00112	0.00373	CcSEcCtD
Oxprenolol—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00112	0.00372	CcSEcCtD
Oxprenolol—Nausea—Miglitol—type 2 diabetes mellitus	0.00111	0.00371	CcSEcCtD
Oxprenolol—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.0011	0.00368	CcSEcCtD
Oxprenolol—Asthenia—Tolazamide—type 2 diabetes mellitus	0.0011	0.00366	CcSEcCtD
Oxprenolol—Sweating increased—Orlistat—type 2 diabetes mellitus	0.00109	0.00364	CcSEcCtD
Oxprenolol—Hypoglycaemia—Losartan—type 2 diabetes mellitus	0.00109	0.00363	CcSEcCtD
Oxprenolol—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00109	0.00361	CcSEcCtD
Oxprenolol—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00109	0.00361	CcSEcCtD
Oxprenolol—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00109	0.00361	CcSEcCtD
Oxprenolol—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.00108	0.0036	CcSEcCtD
Oxprenolol—Arthralgia—Glipizide—type 2 diabetes mellitus	0.00106	0.00353	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.00106	0.00353	CcSEcCtD
Oxprenolol—Headache—Tolbutamide—type 2 diabetes mellitus	0.00106	0.00352	CcSEcCtD
Oxprenolol—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00105	0.00349	CcSEcCtD
Oxprenolol—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00105	0.00349	CcSEcCtD
Oxprenolol—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00104	0.00346	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.00103	0.00344	CcSEcCtD
Oxprenolol—Palpitations—Glimepiride—type 2 diabetes mellitus	0.00103	0.00342	CcSEcCtD
Oxprenolol—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00102	0.00339	CcSEcCtD
Oxprenolol—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.00102	0.00339	CcSEcCtD
Oxprenolol—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00101	0.00338	CcSEcCtD
Oxprenolol—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00101	0.00338	CcSEcCtD
Oxprenolol—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00101	0.00336	CcSEcCtD
Oxprenolol—Sweating increased—Metformin—type 2 diabetes mellitus	0.00101	0.00336	CcSEcCtD
Oxprenolol—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00101	0.00336	CcSEcCtD
Oxprenolol—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00101	0.00335	CcSEcCtD
Oxprenolol—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.001	0.00334	CcSEcCtD
Oxprenolol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.001	0.00333	CcSEcCtD
Oxprenolol—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000997	0.00332	CcSEcCtD
Oxprenolol—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.000988	0.00329	CcSEcCtD
Oxprenolol—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000984	0.00328	CcSEcCtD
Oxprenolol—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000973	0.00324	CcSEcCtD
Oxprenolol—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000972	0.00324	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000971	0.00323	CcSEcCtD
Oxprenolol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000961	0.0032	CcSEcCtD
Oxprenolol—Headache—Tolazamide—type 2 diabetes mellitus	0.000961	0.0032	CcSEcCtD
Oxprenolol—Headache—Linagliptin—type 2 diabetes mellitus	0.000951	0.00317	CcSEcCtD
Oxprenolol—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000943	0.00314	CcSEcCtD
Oxprenolol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00094	0.00313	CcSEcCtD
Oxprenolol—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.000934	0.00311	CcSEcCtD
Oxprenolol—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000934	0.00311	CcSEcCtD
Oxprenolol—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00093	0.0031	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000927	0.00309	CcSEcCtD
Oxprenolol—Insomnia—Glipizide—type 2 diabetes mellitus	0.000921	0.00306	CcSEcCtD
Oxprenolol—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000918	0.00306	CcSEcCtD
Oxprenolol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000911	0.00303	CcSEcCtD
Oxprenolol—Nausea—Tolazamide—type 2 diabetes mellitus	0.000911	0.00303	CcSEcCtD
Oxprenolol—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000906	0.00302	CcSEcCtD
Oxprenolol—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000896	0.00298	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000888	0.00296	CcSEcCtD
Oxprenolol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000888	0.00295	CcSEcCtD
Oxprenolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000886	0.147	CrCbGaD
Oxprenolol—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000882	0.00294	CcSEcCtD
Oxprenolol—Nausea—Acarbose—type 2 diabetes mellitus	0.000876	0.00291	CcSEcCtD
Oxprenolol—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00087	0.0029	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000863	0.00287	CcSEcCtD
Oxprenolol—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000859	0.00286	CcSEcCtD
Oxprenolol—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000856	0.00285	CcSEcCtD
Oxprenolol—Nausea—Nateglinide—type 2 diabetes mellitus	0.000844	0.00281	CcSEcCtD
Oxprenolol—Bradycardia—Metformin—type 2 diabetes mellitus	0.000843	0.00281	CcSEcCtD
Oxprenolol—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000842	0.0028	CcSEcCtD
Oxprenolol—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000841	0.0028	CcSEcCtD
Oxprenolol—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000836	0.00278	CcSEcCtD
Oxprenolol—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000834	0.00278	CcSEcCtD
Oxprenolol—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000833	0.00277	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000833	0.00277	CcSEcCtD
Oxprenolol—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000823	0.00274	CcSEcCtD
Oxprenolol—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000819	0.00273	CcSEcCtD
Oxprenolol—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000817	0.00272	CcSEcCtD
Oxprenolol—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000816	0.00272	CcSEcCtD
Oxprenolol—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000805	0.00268	CcSEcCtD
Oxprenolol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000801	0.00267	CcSEcCtD
Oxprenolol—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000796	0.00265	CcSEcCtD
Oxprenolol—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000796	0.00265	CcSEcCtD
Oxprenolol—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000775	0.00258	CcSEcCtD
Oxprenolol—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000775	0.00258	CcSEcCtD
Oxprenolol—Headache—Repaglinide—type 2 diabetes mellitus	0.000771	0.00257	CcSEcCtD
Oxprenolol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000769	0.00256	CcSEcCtD
Oxprenolol—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000768	0.00256	CcSEcCtD
Oxprenolol—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000767	0.00255	CcSEcCtD
Oxprenolol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000762	0.00254	CcSEcCtD
Oxprenolol—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000757	0.00252	CcSEcCtD
Oxprenolol—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000754	0.00251	CcSEcCtD
Oxprenolol—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000751	0.0025	CcSEcCtD
Oxprenolol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00075	0.0025	CcSEcCtD
Oxprenolol—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000748	0.00249	CcSEcCtD
Oxprenolol—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000739	0.00246	CcSEcCtD
Oxprenolol—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000734	0.00244	CcSEcCtD
Oxprenolol—Hypotension—Glyburide—type 2 diabetes mellitus	0.000732	0.00244	CcSEcCtD
Oxprenolol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000731	0.00243	CcSEcCtD
Oxprenolol—Asthenia—Glipizide—type 2 diabetes mellitus	0.00073	0.00243	CcSEcCtD
Oxprenolol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000728	0.00242	CcSEcCtD
Oxprenolol—Pruritus—Glipizide—type 2 diabetes mellitus	0.00072	0.0024	CcSEcCtD
Oxprenolol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000718	0.00239	CcSEcCtD
Oxprenolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000715	0.118	CrCbGaD
Oxprenolol—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000714	0.00238	CcSEcCtD
Oxprenolol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.0007	0.00233	CcSEcCtD
Oxprenolol—Palpitations—Valsartan—type 2 diabetes mellitus	0.0007	0.00233	CcSEcCtD
Oxprenolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.0007	0.00233	CcSEcCtD
Oxprenolol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000698	0.00232	CcSEcCtD
Oxprenolol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000696	0.00232	CcSEcCtD
Oxprenolol—Palpitations—Orlistat—type 2 diabetes mellitus	0.000691	0.0023	CcSEcCtD
Oxprenolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000691	0.0023	CcSEcCtD
Oxprenolol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00069	0.0023	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000689	0.00229	CcSEcCtD
Oxprenolol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000681	0.00227	CcSEcCtD
Oxprenolol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00068	0.00226	CcSEcCtD
Oxprenolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000679	0.00226	CcSEcCtD
Oxprenolol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000677	0.00225	CcSEcCtD
Oxprenolol—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000674	0.00224	CcSEcCtD
Oxprenolol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000673	0.00224	CcSEcCtD
Oxprenolol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000672	0.00224	CcSEcCtD
Oxprenolol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000667	0.00222	CcSEcCtD
Oxprenolol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000657	0.00219	CcSEcCtD
Oxprenolol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00065	0.00216	CcSEcCtD
Oxprenolol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000648	0.00216	CcSEcCtD
Oxprenolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000645	0.00215	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000641	0.00213	CcSEcCtD
Oxprenolol—Headache—Glipizide—type 2 diabetes mellitus	0.000638	0.00212	CcSEcCtD
Oxprenolol—Palpitations—Metformin—type 2 diabetes mellitus	0.000637	0.00212	CcSEcCtD
Oxprenolol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000636	0.00212	CcSEcCtD
Oxprenolol—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000633	0.00211	CcSEcCtD
Oxprenolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000628	0.00209	CcSEcCtD
Oxprenolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000626	0.00208	CcSEcCtD
Oxprenolol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000619	0.00206	CcSEcCtD
Oxprenolol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000619	0.00206	CcSEcCtD
Oxprenolol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000617	0.00205	CcSEcCtD
Oxprenolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000615	0.00205	CcSEcCtD
Oxprenolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000611	0.00203	CcSEcCtD
Oxprenolol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000606	0.00202	CcSEcCtD
Oxprenolol—Nausea—Glipizide—type 2 diabetes mellitus	0.000605	0.00201	CcSEcCtD
Oxprenolol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000604	0.00201	CcSEcCtD
Oxprenolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000595	0.00198	CcSEcCtD
Oxprenolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000593	0.00197	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000589	0.00196	CcSEcCtD
Oxprenolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000586	0.00195	CcSEcCtD
Oxprenolol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000584	0.00195	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000582	0.00194	CcSEcCtD
Oxprenolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000579	0.00193	CcSEcCtD
Oxprenolol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000578	0.00192	CcSEcCtD
Oxprenolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000577	0.00192	CcSEcCtD
Oxprenolol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000576	0.00192	CcSEcCtD
Oxprenolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000569	0.00189	CcSEcCtD
Oxprenolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000569	0.00189	CcSEcCtD
Oxprenolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000567	0.00189	CcSEcCtD
Oxprenolol—Palpitations—Losartan—type 2 diabetes mellitus	0.000566	0.00188	CcSEcCtD
Oxprenolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000564	0.00188	CcSEcCtD
Oxprenolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000562	0.00187	CcSEcCtD
Oxprenolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000562	0.00187	CcSEcCtD
Oxprenolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000562	0.00187	CcSEcCtD
Oxprenolol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000557	0.00185	CcSEcCtD
Oxprenolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000556	0.00185	CcSEcCtD
Oxprenolol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000554	0.00184	CcSEcCtD
Oxprenolol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000551	0.00183	CcSEcCtD
Oxprenolol—Hypotension—Metformin—type 2 diabetes mellitus	0.00055	0.00183	CcSEcCtD
Oxprenolol—Arthralgia—Losartan—type 2 diabetes mellitus	0.000545	0.00181	CcSEcCtD
Oxprenolol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000544	0.00181	CcSEcCtD
Oxprenolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000537	0.00179	CcSEcCtD
Oxprenolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000537	0.00179	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000536	0.00178	CcSEcCtD
Oxprenolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000536	0.00178	CcSEcCtD
Oxprenolol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000519	0.00173	CcSEcCtD
Oxprenolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000518	0.00173	CcSEcCtD
Oxprenolol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000518	0.00172	CcSEcCtD
Oxprenolol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000512	0.0017	CcSEcCtD
Oxprenolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000511	0.0017	CcSEcCtD
Oxprenolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000509	0.00169	CcSEcCtD
Oxprenolol—Fatigue—Metformin—type 2 diabetes mellitus	0.000507	0.00169	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000506	0.00168	CcSEcCtD
Oxprenolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000505	0.00168	CcSEcCtD
Oxprenolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000505	0.00168	CcSEcCtD
Oxprenolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000505	0.00168	CcSEcCtD
Oxprenolol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000498	0.00166	CcSEcCtD
Oxprenolol—Headache—Glyburide—type 2 diabetes mellitus	0.000491	0.00163	CcSEcCtD
Oxprenolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000489	0.00163	CcSEcCtD
Oxprenolol—Hypotension—Losartan—type 2 diabetes mellitus	0.000488	0.00163	CcSEcCtD
Oxprenolol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000485	0.00162	CcSEcCtD
Oxprenolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000481	0.0016	CcSEcCtD
Oxprenolol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000479	0.00159	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000476	0.00159	CcSEcCtD
Oxprenolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000476	0.00158	CcSEcCtD
Oxprenolol—Insomnia—Losartan—type 2 diabetes mellitus	0.000473	0.00157	CcSEcCtD
Oxprenolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00047	0.00157	CcSEcCtD
Oxprenolol—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000467	0.00156	CcSEcCtD
Oxprenolol—Nausea—Glyburide—type 2 diabetes mellitus	0.000465	0.00155	CcSEcCtD
Oxprenolol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000465	0.00155	CcSEcCtD
Oxprenolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000465	0.00155	CcSEcCtD
Oxprenolol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000464	0.00154	CcSEcCtD
Oxprenolol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00046	0.00153	CcSEcCtD
Oxprenolol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000458	0.00153	CcSEcCtD
Oxprenolol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000457	0.00152	CcSEcCtD
Oxprenolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000457	0.0758	CrCbGaD
Oxprenolol—Pruritus—Orlistat—type 2 diabetes mellitus	0.000452	0.0015	CcSEcCtD
Oxprenolol—Fatigue—Losartan—type 2 diabetes mellitus	0.000451	0.0015	CcSEcCtD
Oxprenolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000442	0.00147	CcSEcCtD
Oxprenolol—Headache—Gliclazide—type 2 diabetes mellitus	0.000441	0.00147	CcSEcCtD
Oxprenolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000439	0.00146	CcSEcCtD
Oxprenolol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000439	0.00146	CcSEcCtD
Oxprenolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000437	0.00145	CcSEcCtD
Oxprenolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000433	0.00144	CcSEcCtD
Oxprenolol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000427	0.00142	CcSEcCtD
Oxprenolol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000422	0.00141	CcSEcCtD
Oxprenolol—Asthenia—Metformin—type 2 diabetes mellitus	0.000422	0.00141	CcSEcCtD
Oxprenolol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000419	0.00139	CcSEcCtD
Oxprenolol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000418	0.00139	CcSEcCtD
Oxprenolol—Pruritus—Metformin—type 2 diabetes mellitus	0.000416	0.00139	CcSEcCtD
Oxprenolol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000413	0.00138	CcSEcCtD
Oxprenolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000409	0.00136	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000408	0.00136	CcSEcCtD
Oxprenolol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000405	0.00135	CcSEcCtD
Oxprenolol—Headache—Valsartan—type 2 diabetes mellitus	0.000405	0.00135	CcSEcCtD
Oxprenolol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000403	0.00134	CcSEcCtD
Oxprenolol—Headache—Orlistat—type 2 diabetes mellitus	0.0004	0.00133	CcSEcCtD
Oxprenolol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000398	0.00133	CcSEcCtD
Oxprenolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000394	0.00131	CcSEcCtD
Oxprenolol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000393	0.00131	CcSEcCtD
Oxprenolol—Dizziness—Metformin—type 2 diabetes mellitus	0.000389	0.0013	CcSEcCtD
Oxprenolol—Fatigue—Ramipril—type 2 diabetes mellitus	0.000386	0.00129	CcSEcCtD
Oxprenolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000385	0.00128	CcSEcCtD
Oxprenolol—Nausea—Valsartan—type 2 diabetes mellitus	0.000384	0.00128	CcSEcCtD
Oxprenolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00038	0.00126	CcSEcCtD
Oxprenolol—Nausea—Orlistat—type 2 diabetes mellitus	0.000379	0.00126	CcSEcCtD
Oxprenolol—Asthenia—Losartan—type 2 diabetes mellitus	0.000375	0.00125	CcSEcCtD
Oxprenolol—Pruritus—Losartan—type 2 diabetes mellitus	0.00037	0.00123	CcSEcCtD
Oxprenolol—Headache—Metformin—type 2 diabetes mellitus	0.000369	0.00123	CcSEcCtD
Oxprenolol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000367	0.00122	CcSEcCtD
Oxprenolol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000358	0.00119	CcSEcCtD
Oxprenolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000354	0.00118	CcSEcCtD
Oxprenolol—Nausea—Metformin—type 2 diabetes mellitus	0.00035	0.00116	CcSEcCtD
Oxprenolol—Headache—Irbesartan—type 2 diabetes mellitus	0.000348	0.00116	CcSEcCtD
Oxprenolol—Dizziness—Losartan—type 2 diabetes mellitus	0.000346	0.00115	CcSEcCtD
Oxprenolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00033	0.0011	CcSEcCtD
Oxprenolol—Nausea—Irbesartan—type 2 diabetes mellitus	0.00033	0.0011	CcSEcCtD
Oxprenolol—Headache—Losartan—type 2 diabetes mellitus	0.000327	0.00109	CcSEcCtD
Oxprenolol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000322	0.00107	CcSEcCtD
Oxprenolol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000317	0.00106	CcSEcCtD
Oxprenolol—Nausea—Losartan—type 2 diabetes mellitus	0.00031	0.00103	CcSEcCtD
Oxprenolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000307	0.00102	CcSEcCtD
Oxprenolol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000296	0.000986	CcSEcCtD
Oxprenolol—Headache—Ramipril—type 2 diabetes mellitus	0.000281	0.000935	CcSEcCtD
Oxprenolol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000278	0.0462	CrCbGaD
Oxprenolol—Nausea—Ramipril—type 2 diabetes mellitus	0.000266	0.000886	CcSEcCtD
Oxprenolol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000184	0.0306	CrCbGaD
Oxprenolol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.53e-05	0.000294	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.53e-05	0.000293	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.52e-05	0.000292	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	3.51e-05	0.000292	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.48e-05	0.000289	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.46e-05	0.000288	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.46e-05	0.000288	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	3.46e-05	0.000288	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	3.46e-05	0.000288	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	3.46e-05	0.000288	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.46e-05	0.000287	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.45e-05	0.000287	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.45e-05	0.000287	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.45e-05	0.000286	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.43e-05	0.000286	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.43e-05	0.000285	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.38e-05	0.000281	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.38e-05	0.000281	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.37e-05	0.00028	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.37e-05	0.00028	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.35e-05	0.000279	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.32e-05	0.000276	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	3.32e-05	0.000276	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	3.32e-05	0.000276	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.31e-05	0.000275	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	3.31e-05	0.000275	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.28e-05	0.000273	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.28e-05	0.000273	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	3.28e-05	0.000273	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.23e-05	0.000269	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.21e-05	0.000267	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.2e-05	0.000266	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.2e-05	0.000266	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.19e-05	0.000265	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.19e-05	0.000265	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.19e-05	0.000265	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.19e-05	0.000265	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	3.15e-05	0.000262	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.15e-05	0.000262	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.14e-05	0.000261	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.14e-05	0.000261	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.13e-05	0.00026	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.12e-05	0.000259	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.12e-05	0.000259	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.1e-05	0.000258	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.09e-05	0.000257	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.09e-05	0.000257	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.08e-05	0.000256	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.08e-05	0.000256	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.08e-05	0.000256	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.07e-05	0.000255	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.04e-05	0.000252	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.03e-05	0.000252	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.02e-05	0.000251	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.02e-05	0.000251	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.02e-05	0.000251	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.02e-05	0.000251	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.99e-05	0.000248	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.97e-05	0.000247	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.96e-05	0.000246	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.96e-05	0.000246	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.92e-05	0.000243	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.9e-05	0.000241	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	2.9e-05	0.000241	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.84e-05	0.000236	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.81e-05	0.000234	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.8e-05	0.000233	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.76e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.76e-05	0.00023	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.75e-05	0.000229	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.74e-05	0.000228	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.72e-05	0.000226	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	2.71e-05	0.000226	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	2.71e-05	0.000225	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.71e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.71e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.7e-05	0.000225	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.7e-05	0.000225	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.7e-05	0.000224	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	2.66e-05	0.000221	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.66e-05	0.000221	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.65e-05	0.00022	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.62e-05	0.000218	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.62e-05	0.000218	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.62e-05	0.000218	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.62e-05	0.000218	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.59e-05	0.000215	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	2.59e-05	0.000215	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.54e-05	0.000211	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.54e-05	0.000211	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.53e-05	0.00021	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.51e-05	0.000209	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.51e-05	0.000209	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.49e-05	0.000207	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.48e-05	0.000206	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	2.47e-05	0.000205	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.42e-05	0.000201	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	2.41e-05	0.0002	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.4e-05	0.0002	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.38e-05	0.000198	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.35e-05	0.000196	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.35e-05	0.000195	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.35e-05	0.000195	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	2.35e-05	0.000195	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.34e-05	0.000195	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.34e-05	0.000194	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.33e-05	0.000194	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.33e-05	0.000194	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.32e-05	0.000193	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.31e-05	0.000192	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.3e-05	0.000191	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.3e-05	0.000191	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.29e-05	0.00019	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.28e-05	0.000189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.27e-05	0.000189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.26e-05	0.000188	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.26e-05	0.000188	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.24e-05	0.000186	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.22e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.22e-05	0.000185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.21e-05	0.000184	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.19e-05	0.000182	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.18e-05	0.000181	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	2.18e-05	0.000181	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.17e-05	0.00018	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.14e-05	0.000178	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.14e-05	0.000178	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.12e-05	0.000177	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.12e-05	0.000176	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	2.11e-05	0.000176	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.1e-05	0.000174	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.08e-05	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.08e-05	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.08e-05	0.000173	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.08e-05	0.000173	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	2.08e-05	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.07e-05	0.000172	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	2.07e-05	0.000172	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	2.05e-05	0.00017	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.04e-05	0.000169	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.03e-05	0.000169	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.01e-05	0.000167	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2e-05	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.99e-05	0.000166	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.95e-05	0.000163	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	1.95e-05	0.000162	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	1.91e-05	0.000159	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.87e-05	0.000155	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.87e-05	0.000155	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.87e-05	0.000155	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.86e-05	0.000155	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.86e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.86e-05	0.000154	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.83e-05	0.000152	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.82e-05	0.000152	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.82e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.82e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.82e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.82e-05	0.000151	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.82e-05	0.000151	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.82e-05	0.000151	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	1.8e-05	0.00015	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.8e-05	0.000149	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.78e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.78e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.78e-05	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.78e-05	0.000148	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	1.77e-05	0.000147	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.76e-05	0.000146	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.71e-05	0.000143	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.71e-05	0.000142	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.69e-05	0.00014	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.69e-05	0.00014	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.68e-05	0.000139	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.65e-05	0.000137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.62e-05	0.000135	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	1.62e-05	0.000135	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.62e-05	0.000135	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.62e-05	0.000135	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.59e-05	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	1.55e-05	0.000129	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	1.55e-05	0.000129	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.55e-05	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.53e-05	0.000127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	1.52e-05	0.000126	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.5e-05	0.000125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.5e-05	0.000125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.49e-05	0.000124	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.49e-05	0.000124	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.47e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.47e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.46e-05	0.000122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.43e-05	0.000119	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-05	0.000118	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.4e-05	0.000116	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.4e-05	0.000116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.4e-05	0.000116	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.39e-05	0.000116	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.37e-05	0.000114	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.36e-05	0.000113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.36e-05	0.000113	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.33e-05	0.000111	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.33e-05	0.000111	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.33e-05	0.000111	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.29e-05	0.000108	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.28e-05	0.000107	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.27e-05	0.000106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.25e-05	0.000104	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.24e-05	0.000103	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.24e-05	0.000103	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.21e-05	0.0001	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.19e-05	9.91e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.17e-05	9.7e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.16e-05	9.61e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.15e-05	9.55e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-05	9.51e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.14e-05	9.49e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.13e-05	9.4e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.12e-05	9.34e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.12e-05	9.33e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-05	9.09e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.09e-05	9.04e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-05	8.99e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.07e-05	8.89e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-05	8.89e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.07e-05	8.86e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.06e-05	8.81e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.06e-05	8.79e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-05	8.75e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.04e-05	8.62e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.01e-05	8.38e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.86e-06	8.19e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.81e-06	8.16e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.6e-06	7.98e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.28e-06	7.71e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.1e-06	7.57e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.01e-06	7.49e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.83e-06	7.34e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.81e-06	7.32e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.64e-06	7.18e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.34e-06	6.94e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	7.98e-06	6.63e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	7.98e-06	6.63e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.3e-06	6.07e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	7.13e-06	5.92e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.79e-06	5.64e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.64e-06	5.52e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.26e-06	5.21e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.13e-06	5.09e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.67e-06	3.05e-05	CbGpPWpGaD
